β-catenin (CTNNB1) demonstrated elevated centrality values relative to other ranked genes in the network, suggesting its potential as a target for pathway-specific therapies or drug interventions in Ov-CCA (Fig 4B). The gene discussed is CTNNB1; the disease is cholangiocarcinoma.